Annual Cash & Cash Equivalents
$6.94 M
-$33.67 M-82.90%
December 31, 2022
Summary
- As of February 8, 2025, UTRS annual cash & cash equivalents is $6.94 million, with the most recent change of -$33.67 million (-82.90%) on December 31, 2022.
- During the last 3 years, UTRS annual cash & cash equivalents has fallen by -$20.14 million (-74.37%).
- UTRS annual cash & cash equivalents is now -82.90% below its all-time high of $40.61 million, reached on December 31, 2021.
Performance
UTRS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$11.13 M
-$4.59 M-29.20%
September 30, 2023
Summary
- As of February 8, 2025, UTRS quarterly cash and cash equivalents is $11.13 million, with the most recent change of -$4.59 million (-29.20%) on September 30, 2023.
- Over the past year, UTRS quarterly cash and cash equivalents has dropped by -$3.99 million (-26.38%).
- UTRS quarterly cash and cash equivalents is now -72.60% below its all-time high of $40.61 million, reached on December 31, 2021.
Performance
UTRS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
UTRS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.9% | -26.4% |
| 3 y3 years | -74.4% | - |
| 5 y5 years | -74.4% | - |
UTRS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.9% | at low | -72.6% | +60.3% |
| 5 y | 5-year | -82.9% | at low | -72.6% | +81.5% |
| alltime | all time | -82.9% | at low | -72.6% | +81.5% |
Minerva Surgical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $11.13 M(-29.2%) |
| Jun 2023 | - | $15.71 M(-37.8%) |
| Mar 2023 | - | $25.25 M(+263.8%) |
| Dec 2022 | $6.94 M | $6.94 M(-54.1%) |
| Sep 2022 | - | $15.11 M(-32.5%) |
| Jun 2022 | - | $22.39 M(-19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $27.90 M(-31.3%) |
| Dec 2021 | $40.61 M(+133.9%) | $40.61 M(+562.7%) |
| Sep 2021 | - | $6.13 M(-47.2%) |
| Jun 2021 | - | $11.62 M(-33.1%) |
| Dec 2020 | $17.36 M(-35.9%) | $17.36 M |
| Dec 2019 | $27.09 M | - |
FAQ
- What is Minerva Surgical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Minerva Surgical?
- What is Minerva Surgical annual cash & cash equivalents year-on-year change?
- What is Minerva Surgical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Minerva Surgical?
- What is Minerva Surgical quarterly cash and cash equivalents year-on-year change?
What is Minerva Surgical annual cash & cash equivalents?
The current annual cash & cash equivalents of UTRS is $6.94 M
What is the all time high annual cash & cash equivalents for Minerva Surgical?
Minerva Surgical all-time high annual cash & cash equivalents is $40.61 M
What is Minerva Surgical annual cash & cash equivalents year-on-year change?
Over the past year, UTRS annual cash & cash equivalents has changed by -$33.67 M (-82.90%)
What is Minerva Surgical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of UTRS is $11.13 M
What is the all time high quarterly cash and cash equivalents for Minerva Surgical?
Minerva Surgical all-time high quarterly cash and cash equivalents is $40.61 M
What is Minerva Surgical quarterly cash and cash equivalents year-on-year change?
Over the past year, UTRS quarterly cash and cash equivalents has changed by -$3.99 M (-26.38%)